Collegium Pharmaceutical Inc. Company Profile
NASDAQ: COLLHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Collegium Pharmaceutical at a glance
Collegium Pharmaceutical Inc. (NASDAQ: COLL) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Stoughton, MA. Collegium Pharmaceutical is led by Mr. Vikram Karnani and employs about 423 people. The company's shares have traded publicly since 2015.
At a market capitalization of $783.4 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001267565, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Collegium Pharmaceutical do?
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management. The company's portfolio includes Jornay PM, a central nervous system stimulant prescription medicine that contains methylphenidate HCl for the treatment of attention deficit hyperactivity disorder; Belbuca, a buccal film that contains buprenorphine for severe and persistent pain that requires an extended treatment period; Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone for the management of pain severe enough to require daily; Nucynta ER and Nucynta IR, which are extended-release and immediate-release oral formulations of tapentadol, indicated for the management of acute, severe, and persistent pain; and Symproic, an oral formulation of naldemedine for the treatment of opioid-induced constipation in adult patients with chronic non-cancer pain. Collegium Pharmaceutical, Inc. was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. The company was incorporated in 2002 and is headquartered in Stoughton, Massachusetts.
Business description based on the company's public filings.
Company information
- Legal name
- Collegium Pharmaceutical Inc.
- Ticker
- NASDAQ: COLL
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- CEO
- Mr. Vikram Karnani
- Employees
- 423
- Headquarters
- 100 Technology Center Drive, Stoughton, MA, United States
- Phone
- 781 713 3699
- Website
- collegiumpharma.com
- IPO year
- 2015
- Market cap
- $783.41M
- SEC CIK
- 0001267565
- Latest annual report
- 10-K · Feb 26, 2026
Companies similar to Collegium Pharmaceutical
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| SNDXSyndax Pharmaceuticals Inc. | 8.72 | -4.49% | $785.05M | vs COLL |
| IRWDIronwood Pharmaceuticals Inc. Class A | 4.70 | -0.21% | $778.09M | vs COLL |
| VSTMVerastem Inc. | 6.33 | -7.73% | $797.67M | vs COLL |
| ORICOric Pharmaceuticals Inc. | 7.36 | -4.42% | $764.94M | vs COLL |
| RIGLRigel Pharmaceuticals Inc. | 40.09 | -2.67% | $754.89M | vs COLL |
| ARDXArdelyx Inc. | 2.99 | -2.29% | $751.60M | vs COLL |
| CRVSCorvus Pharmaceuticals Inc. | 9.67 | -3.40% | $815.69M | vs COLL |
| IVAInventiva S.A. American Depository Shares | 3.14 | -8.99% | $750.78M | vs COLL |